U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07712731) titled 'HPP737 in Adult Patients With Plaque Psoriasis' on July 07.
Brief Summary: The goal of this clinical trial is to learn if drug HPP737 works to treat moderate-to-severe plaque psoriasis in adults. It will also learn about the safety of drug HPP737. The main questions it aims to answer are:
Does drug HPP737 improve psoriasis severity compared to an active control drug, as measured by the proportion of patients achieving a significant reduction in the Psoriasis Area and Severity Index (PASI) score and other standardized assessments? What medical problems do participants have when taking drug HPP737? Researchers will compare drug HPP73...